Skip to main content

RAD · NZX

Radius Residential Care (RAD)

Healthcare / Aged careCovered: FY23 - HY278 published briefings

Radius Residential Care is an NZX-listed healthcare / aged care company. Its latest covered result is HY27, with FY23 - HY27 of source-backed result history on Annolyse.

Latest result

Latest metrics

HY27, released 11 November 2026

← Swipe to view more
RAD latest metrics
MetricValueChange
Revenue$108.6m↑ +8.4%
EBITDA$16.6m↑ +11.2%
NPAT$8m↑ +27.3%
Operating cash flow$6.5m↓ -51.1%
OCF / EBITDA %39.3%↓ -50.0pp
Net debt$90.5m↑ +42.2%
Net debt / EBITDA5.46x↑ +27.9%
ROE %9.8%↑ +0.7pp
DPS1.1c↑ +10.0%
Payout ratio vs NPAT %38.9%↓ -5.9pp

Source: latest published briefing (HY27, released 11 November 2026). Change compares against the prior equivalent period: HY26, released 19 November 2025.

Valuation

Valuation

Trailing P/E, EV/EBITDA, price-to-book and price-to-free-cash-flow ratios combine the latest available close with filing data. They are comparative measures, not forecasts or recommendations.

Prices as at close, 20 November 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$113.4m

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

10.1x

i

Recent market cap compared with trailing earnings.

EPS

0.04

i

Recent filing-derived earnings per share.

PEG

0.38x

i

P/E compared with recent earnings growth.

EV/EBITDA

7.02x

i

Enterprise value compared with recent EBITDA.

P/FCF

Not available

i

Not meaningful when free cash flow is negative or unavailable.

P/B

1.39x

i

Market value compared with latest reported equity.

Income and investment-company measures

Yield and investment-company valuation where supported.

Dividend yield

5.5%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Price history

Daily closes use the full available width, with hover and touch values for each observation. Expand the chart to see more detail.

Share price

Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.

Loading chart...

P/E over time

Filing-period markers only: EOD close on or before each release date divided by filing-derived trailing NPAT where both inputs verify.

Loading chart...

Ask about RAD

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask company questions.

What changed in the latest result?What is unusual in the historical context?How has cash conversion changed over time?Compare this company with CNU.

Checking account...

Financial history

Performance over time

The latest period is shown first.

← Swipe to view more
RAD metric history
MetricHY276 MONTHS11 November 2026FY2612 MONTHS13 May 2026HY266 MONTHS19 November 2025FY2512 MONTHS21 May 2025HY256 MONTHS25 November 2024FY2412 MONTHS29 May 2024HY246 MONTHS27 November 2023FY2312 MONTHS29 May 2023Trend
Revenue$108.6m$200.1m$100.2m$175.3m$85.4m$168.7m$83.3m$146.3m
Chart
Revenue growth %8.4%14.2%19.0%3.9%2.5%15.4%19.2%10.8%
Chart
EBITDA$16.6m$27.4m$14.9m$23.5m$9.6m$20.9m$10.5m$14.2m
Chart
EBITDA margin %15.3%13.7%14.9%13.4%11.3%12.4%12.5%9.7%
Chart
PBT$10m$14.3m$8.5m$10.5m$2.8m$3.6m$1.6m-$3m
Chart
PBT growth %17.3%36.2%203.6%191.7%75.0%—-27.3%—
Chart
NPAT$8m$9.5m$6.3m$7m$2m-$8.5m$1.4m-$2.1m
Chart
NPAT growth %26.7%35.7%215.0%—42.9%—-17.6%—
Chart
Operating cash flow$6.5m$25.1m$13.3m$20.1m$6.6m$14.1m$5.6m$4m
Chart
OCF / EBITDA %39.3%91.8%89.3%85.4%68.5%67.4%53.6%28.4%
Chart
FCF pre-lease$0.44m$9m$9.6m$13.7m$3.7m$10.6m$3.7m-$54.6m
Chart
DPS1.1c1.2c1.0c0.8c0.7c0.7c0.0c—
Chart
Payout ratio vs NPAT %38.9%66.1%44.8%55.8%94.2%———
Chart
Annual payout ratio vs EPS %—66.1%—55.8%————
Chart
ROE %9.8%12.4%Outside range high roe. 12.4%; 3-period range -13.2% to 10.6%. ROE: 12.4%, above normal range; 3-period mean -1.8%, range -13.2%-10.6%.9.1%10.6%3.1%-13.2%1.9%-2.9%
Chart
  • FY26 ROE %: Outside range high roe. 12.4%; 3-period range -13.2% to 10.6%. ROE: 12.4%, above normal range; 3-period mean -1.8%, range -13.2%-10.6%.
Net debt$90.5m$68.7m$63.7m$67.7m$73.2m$73.5m$96.8m$100.1m
Chart
Net debt / EBITDA5.46x2.51x4.27x2.89x7.59x3.51x9.26x7.05x
Chart
Debtor days2421Outside range low debtor days. 21d; 3-period range 24d to 33d. Debtor days: 21.2 days, below normal range; 3-period mean 27.4 days, range 24.0 days-32.6 days.232426263033
Chart
  • FY26 Debtor days: Outside range low debtor days. 21d; 3-period range 24d to 33d. Debtor days: 21.2 days, below normal range; 3-period mean 27.4 days, range 24.0 days-32.6 days.
Inventory days2Outside range high inventory days. 2d; 3-period range 1d to 2d. Inventory days: 1.6 days, above normal range; 3-period mean 1.3 days, range 1.1 days-1.5 days.1Outside range low inventory days. 1d; 3-period range 1d to 2d. Inventory days: 1.1 days, below normal range; 3-period mean 1.4 days, range 1.2 days-1.9 days.111122
Chart
  • FY26 Inventory days: Outside range low inventory days. 1d; 3-period range 1d to 2d. Inventory days: 1.1 days, below normal range; 3-period mean 1.4 days, range 1.2 days-1.9 days.
  • HY27 Inventory days: Outside range high inventory days. 2d; 3-period range 1d to 2d. Inventory days: 1.6 days, above normal range; 3-period mean 1.3 days, range 1.1 days-1.5 days.
Total assets$400.5m$374.4m$355.9m$339.6m$330.5m$334.7m$355m$356.6m
Chart

Reference: annolyse.ai/companies/rad

Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.

Filing-only history charts

These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.

Revenue

Reported revenue across covered periods.

Loading chart...

Revenue growth

Like-period revenue growth where comparable.

Loading chart...

EBITDA-equivalent

Company-specific earnings measure where disclosed.

Loading chart...

EBITDA margin

EBITDA-equivalent margin where revenue and earnings are source-backed.

Loading chart...

NPAT

Statutory profit after tax.

Loading chart...

Operating cash flow

Cash generated from operations.

Loading chart...

More financial metrics

Additional filing-backed metrics for this company. Each point links to the relevant published briefing.

OCF / EBITDA

Cash conversion against earnings.

Loading chart...

FCF pre-lease

Operating cash flow less capex before leases.

Loading chart...

ROE

Return on equity.

Loading chart...
  • FY26 RAD FY: Outside range high roe. 12.4%; 3-period range -13.2% to 10.6%. ROE: 12.4%, above normal range; 3-period mean -1.8%, range -13.2%-10.6%.

Net debt

Borrowings less cash; negative values indicate net cash.

Loading chart...

Net debt / EBITDA

Leverage ratio, suppressed where earnings are not meaningful.

Loading chart...

DPS

Dividend per share declared for the period.

Loading chart...

Payout ratio

Dividend payout against statutory NPAT.

Loading chart...

Debtor days

Receivables days where the working-capital inputs are source-backed.

Loading chart...
  • FY26 RAD FY: Outside range low debtor days. 21d; 3-period range 24d to 33d. Debtor days: 21.2 days, below normal range; 3-period mean 27.4 days, range 24.0 days-32.6 days.

Inventory days

Inventory days where the working-capital inputs are source-backed.

Loading chart...
  • FY26 RAD FY: Outside range low inventory days. 1d; 3-period range 1d to 2d. Inventory days: 1.1 days, below normal range; 3-period mean 1.4 days, range 1.2 days-1.9 days.
  • HY27 RAD HY: Outside range high inventory days. 2d; 3-period range 1d to 2d. Inventory days: 1.6 days, above normal range; 3-period mean 1.3 days, range 1.1 days-1.5 days.

Operating working-capital movement

Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.

Loading chart...
  • HY27 RAD: Outside range high operating working-capital movement. $2.1m; 3-period range $-1.5m to $0.2m. Operating working-capital movement: NZ$2.1m, above normal range; 1/3 prior periods had builds averaging NZ$0.2m, and 2 had releases averaging NZ$-1.0m.

The setup & the reality

FY26 → HY27 Follow-through

The latest result is checked against what the prior briefing said to watch.

Historical setup

What FY26 said to watch

Previous analysisFY26Result releasedAnnolyse analysis published

From PBT rose36.2%; operating cash conversion was 91.8% and capital spending also increased

The arithmetic implies H2 reported EBITDA of NZ$12.5m and reported NPAT of approximately NZ$3.1m. These historical residuals should not be annualised into an underlying earnings forecast. A reconciliation of reported and underlying earnings, together with any forward guidance, is needed to assess FY27 expectations.

Open questions

Open questions from FY26

  • Why did H2 NPAT roughly halve versus H1 when implied H2 reported EBITDA fell only modestly?
  • What share of the 14.2% revenue growth is organic versus the Cibus full-year roll-on?
  • Does the NZ$16.1m capex level represent a sustained step-up in the build programme or a one-year catch-up against the "capital-light" framing?
  • How durable is the 91.8% cash conversion if capex stays at 8% of revenue and net debt edges higher?
  • What level of FY27 underlying EBITDA and AFFO-based dividend coverage does management see at the current payout ratio?

This briefing cannot assess bed-level occupancy, average resident-day rates or EBITDAR-per-bed trajectory beyond the headline figure, none of which are quantified in the supplied excerpts.

Latest result sources

Primary issuer documents used for the HY27 briefing. Document labels are preserved from the publication record; Annolyse does not relabel every financial report as an annual report.

Current period

RAD 1H27 Interim Report

HY27 / financial report

RAD 1H27 Investor Presentation

HY27 / results presentation

RAD 1H27 Media Release

HY27 / media release

RAD 1H27 NZX Results Announcement

HY27 / results announcement

Prior comparable period

RAD 1H26 Interim Report

HY26 / financial report

RAD 1H26 Investor Presentation

HY26 / results presentation

RAD 1H26 Media Release

HY26 / media release

RAD 1H26 NZX Results Announcement

HY26 / results announcement

Full-year context

Radius Care Annual Report 2026

FY26 / financial report

Release context

RAD Upgraded Outlook and 2025 ASM Materials

HY26 / commentary

RAD 2026 ASM Presentation

HY27 / commentary

Peer context

Aged care comparison set

These companies share the same curated sub-sector label. Their reporting definitions can still differ, so compare the underlying measures before ranking them.

Archive

Briefing archive

The full chronological archive contains every published result briefing.

Open all 8 result briefings

Get notified when RAD publishes

Get the next Radius Residential Care result briefing and five-year history updates by email.